Treatment is a long-term programme and there is no clinical benefit to rushing the titration process at the expense of tolerability
Monitoring thyroid function every three to six months during active GLP-1 therapy, and specifically requesting free T3 along with TSH and free T4, helps catch these shifts early
doi: 10.1016/j.postharvbio.2015.02.015 23 HornbacherJ.RumlowA.PallmannP.TurciosA
Because peptides typically break down quickly in the digestive tract, most are administered through injections
It also may involve the creation of a new belly button
Related Stories Study identifies top predictors for weight loss using tirzepatide Exercise, not liraglutide alone, drives vascular gains after obesity-related weight loss Weight loss drugs may reduce binge eating disorder symptoms For GLP-1 analog monotherapy patients, the percent TBWL was computed from baseline to six and 12 months